Skip to main content
. Author manuscript; available in PMC: 2023 Dec 8.
Published in final edited form as: Prev Med. 2023 Feb 10;169:107448. doi: 10.1016/j.ypmed.2023.107448

Table 1.

Sample characteristics.

 
Intervention
Control
 
n = 417
n = 460
  n (%) n (%)
Gender
 Female 209 (50%) 204 (44%)
 Male 208 (50%) 256 (56%)
Ethnicity
 Latino 358 (86%) 390 (85%)
 Non-Latino white 36 (7%) 46 (10%)
 Non-Latino other 20 (5%) 21 (5%)
 Not reported 3 (1%) 3 (1%)
Insurance
 Medi-Cal 283 (74%) 255 (52%)
 Uninsured 11 (3%) 8 (2%)
 Private 1 (<1%) 0 (0%)
 Not reported 122 (32%) 197 (40%)
Reminder type (intervention group, n = 417)
 Mailed letter 158 (38%)
 Text message 139 (33%)
 Robocall 120 (28%)
HPV vaccine dose group
 Due for 1st vaccine dose 249 (60%) 309 (67%)
 Due for 2nd vaccine dose 168 (40%) 151 (33%)
Outcomes (at 4-month follow-up)
 Received next-dose vaccine 94 (23%) 56 (12%)
 Reminder delivered (intervention group) 352 (84%)